Tempest Therapeutics, Inc. Interest Expense on Debt
Tempest Therapeutics, Inc. (TPST) reported Interest Expense on Debt of $200.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-11.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2020-03-11
- Tempest Therapeutics, Inc. interest expense, debt for fiscal 2018 was $200.00K.
| Period end | Interest Expense, Debt 12 month |
|---|---|
| 2018-12-31 | $200.00K 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |